Safety and Biological Efficacy of a Lipid–CFTR Complex for Gene Transfer in the Nasal Epithelium of Adult Patients with Cystic Fibrosis
Open Access
- 1 January 2000
- journal article
- clinical trial
- Published by Elsevier in Molecular Therapy
- Vol. 1 (1) , 105-114
- https://doi.org/10.1006/mthe.1999.0009
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- The diagnosis of cystic fibrosis: A consensus statementThe Journal of Pediatrics, 1998
- A Double-Blind, Placebo Controlled, Dose Ranging Study to Evaluate the Safety and Biological Efficacy of the Lipid-DNA Complex GR213487B in the Nasal Epithelium of Adult Patients with Cystic Fibrosis. Glaxo Wellcome Research and Development Ltd., London, EnglandHuman Gene Therapy, 1998
- A low rate of cell proliferation and reduced DNA uptake limit cationic lipid-mediated gene transfer to primary cultures of ciliated human airway epitheliaGene Therapy, 1997
- Comparison of DNA-lipid complexes and DNA alone for gene transfer to cystic fibrosis airway epithelia in vivo.Journal of Clinical Investigation, 1997
- Efficient in vivo delivery of DNA to pulmonary cells using the novel lipid EDMPCGene Therapy, 1997
- Evidence for safety and efficacy of DOTAP cationic liposome mediated CFTR gene transfer to the nasal epithelium of patients with cystic fibrosisGene Therapy, 1997
- Nasal and Bronchoalveolar Lavage Fluid Cytokines in Early Cystic FibrosisThe Journal of Infectious Diseases, 1997
- Aerosol Administration of a Recombinant Adenovirus Expressing CFTR to Cystic Fibrosis Patients: A Phase I Clinical TrialHuman Gene Therapy, 1997
- Management of Pulmonary Disease in Patients with Cystic FibrosisNew England Journal of Medicine, 1996
- Adenovirus-mediated gene transfer transiently corrects the chloride transport defect in nasal epithelia of patients with cystic fibrosisPublished by Elsevier ,1993